Relmada Therapeutics Inc (RLMD)

Nov 14, 2024

Relmada Therapeutics initiates Phase 1 dosing with REL-P11 - TipRanks

Nov 14, 2024

Nov 14, 2024

Relmada Therapeutics Initiates Phase 1 Dosing with REL-P11 for Metabolic Disease - The Manila Times

Nov 14, 2024

Nov 11, 2024

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Nov 10, 2024

Earnings call: Relmada Therapeutics reports Q3 financials, focuses on REL-1017 - Investing.com Nigeria

Nov 10, 2024

Nov 08, 2024

Relmada Therapeutics hopes to hit big milestones by year-end - Green Market Report

Nov 08, 2024

Nov 08, 2024

Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights: Navigating Financial ... - Yahoo Finance UK

Nov 08, 2024

Nov 08, 2024

Relmada Therapeutics Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024

Relmada Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024 - Quantisnow

Nov 07, 2024

Nov 07, 2024

Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - PR Newswire

Nov 07, 2024

Nov 05, 2024

Relmada Therapeutics (RLMD) Set to Announce Earnings on Thursday - MarketBeat

Nov 05, 2024

Oct 22, 2024

3 US Penny Stocks To Monitor In October 2024 - Simply Wall St

Oct 22, 2024

Oct 18, 2024

Q3 Earnings Estimate for RLMD Issued By Leerink Partnrs - MarketBeat

Oct 18, 2024

Oct 13, 2024

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Shares Purchased by Renaissance Technologies LLC - Defense World

Oct 13, 2024

Oct 09, 2024

Relmada Therapeutics (NASDAQ:RLMD) Shares Down 0.3%Should You Sell? - MarketBeat

Oct 09, 2024

Sep 24, 2024

Roblox Corp general counsel sells $774,810 in stock By Investing.com - Investing.com Canada

Sep 24, 2024

Sep 24, 2024

Roblox Corporation [RBLX] moved down -1.09: Why It’s Important - The DBT News

Sep 24, 2024

Sep 24, 2024

RBLX (Roblox Corporation) may reap gains as insiders became active recently - Knox Daily

Sep 24, 2024

Sep 24, 2024

Hancock Whitney Corp Reduces Stake in Relx Plc (NYSE:RELX) - Defense World

Sep 24, 2024

Sep 23, 2024

Bet on a Slow March Higher in Roblox (NYSE:RBLX) Stock with a Credit Spread - Nasdaq

Sep 23, 2024

Sep 23, 2024

RELX rises Monday, outperforms market - MarketWatch

Sep 23, 2024

Sep 21, 2024

Relx Plc (NYSE:RELX) Shares Bought by Mercer Global Advisors Inc. ADV - Defense World

Sep 21, 2024

Sep 20, 2024

Financial Health Report: Relmada Therapeutics Inc (RLMD)’s Ratios Tell a Tale - The Dwinnex

Sep 20, 2024

Sep 20, 2024

What's Going On With Richtech Robotics Stock? - Benzinga

Sep 20, 2024

Sep 20, 2024

Relx (NYSE:RELX) Hits New 12-Month High at $48.32 - MarketBeat

Sep 20, 2024

Sep 19, 2024

A new trading data show Relmada Therapeutics Inc (RLMD) is showing positive returns. - SETE News

Sep 19, 2024

Sep 19, 2024

Relmada Therapeutics (NASDAQ:RLMD) Stock Rating Upgraded by Jefferies Financial Group - Defense World

Sep 19, 2024

Sep 18, 2024

Understanding the Risks of Investing in Relmada Therapeutics Inc (RLMD) - Knox Daily

Sep 18, 2024

Sep 18, 2024

Why ResMed Stock Tumbled by 5% Today - The Motley Fool

Sep 18, 2024

Sep 18, 2024

Monitoring Collegium Pharmaceutical Inc (COLL) after recent insider movements - Knox Daily

Sep 18, 2024

Sep 18, 2024

Is Marvell Technology, Inc. (MRVL) The Worst 5G Stock to Buy According to Short Sellers? - Yahoo Finance

Sep 18, 2024

Sep 18, 2024

Relmada Therapeutics (NASDAQ:RLMD) Raised to Buy at Jefferies Financial Group - MarketBeat

Sep 18, 2024

Sep 17, 2024

Relmada Therapeutics Inc Inc. (RLMD) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Sep 17, 2024

Sep 17, 2024

Relmada stock jumps as Jefferies upgrades (NASDAQ:RLMD) - Seeking Alpha

Sep 17, 2024

Sep 17, 2024

Relmada stock's "risk/reward setup" could lead to big upsideJefferies - Investing.com

Sep 17, 2024

Sep 17, 2024

Finansavisen - Finansavisen

Sep 17, 2024

Sep 16, 2024

Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm - PR Newswire

Sep 16, 2024

Sep 13, 2024

Relmada Therapeutics Inc (RLMD) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Sep 13, 2024

Sep 13, 2024

Insider Spends US$395k Buying More Shares In Relmada Therapeutics - Yahoo Finance

Sep 13, 2024

Sep 12, 2024

Relmada Therapeutics CFO buys $149,700 in company stock - Investing.com India

Sep 12, 2024

Sep 12, 2024

Analyst sustains stock target, outperform on Relmada amid insider buys - Investing.com India

Sep 12, 2024

Sep 12, 2024

Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Therapeutics Inc (RLMD) - Yahoo Finance

Sep 12, 2024

Sep 12, 2024

Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Th - GuruFocus.com

Sep 12, 2024

Sep 12, 2024

Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Therapeutics Inc (RLMD) By GuruFocus - Investing.com Canada

Sep 12, 2024

Sep 12, 2024

Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140 - GuruFocus.com

Sep 12, 2024

Sep 12, 2024

Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140,000 Shares By GuruFocus - Investing.com Canada

Sep 12, 2024

Sep 11, 2024

Relmada Therapeutics director buys $33,280 in company stock - Investing.com India

Sep 11, 2024

Sep 11, 2024

Relmada therapeutics CEO acquires shares worth over $395k - Investing.com India

Sep 11, 2024

Sep 11, 2024

Relmada Therapeutics director buys $33,280 in company stock By Investing.com - Investing.com Canada

Sep 11, 2024

Sep 11, 2024

Insider Buying: Relmada Therapeutics, Inc. (NASDAQ:RLMD) CFO Buys 8,194 Shares of Stock - MarketBeat

Sep 11, 2024

Sep 11, 2024

Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140,000 Shares - Yahoo Finance

Sep 11, 2024

Sep 10, 2024

Relmada Therapeutics (NASDAQ:RLMD) Trading Up 16.3% - MarketBeat

Sep 10, 2024

Sep 10, 2024

Relmada Therapeutics (NASDAQ:RLMD) Trading 16.3% Higher - Defense World

Sep 10, 2024

Sep 06, 2024

Insiders Who Purchased US$663.4k Of Relmada Therapeutics Stock May Not Have Expected 14% Tumble - Simply Wall St

Sep 06, 2024

Sep 02, 2024

Ratios Uncovered: Breaking Down Relmada Therapeutics Inc (RLMD)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 02, 2024

Aug 21, 2024

Will Relmada Therapeutics (NASDAQ:RLMD) Spend Its Cash Wisely? - Yahoo Finance

Aug 21, 2024

Aug 19, 2024

Relmada Therapeutics to Participate in the Goldman Sachs 45th An - GuruFocus.com

Aug 19, 2024